Tumour growth can also be limited by inhibition of the transcription factor NF‐κB (nuclear factor kappa‐light‐chain‐enhancer of activated B cells), a major driver of tumour progression with a key impact on cell cycle regulation and apoptosis. This evidence concerns the gene NFKB1 and neoplasm.